Hwail Pharmaceutical Co.,Ltd. (KOSDAQ: 061250)

Hwail Pharmaceutical Co.,Ltd. Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Oct 11, 2024	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Market Capitalization	112,435	109,671	87,493	78,703	80,502	97,411
Market Cap Growth	11.11%	25.35%	11.17%	-2.23%	-17.36%	168.23%
Enterprise Value	102,410	115,940	109,331	87,464	95,297	107,903
Last Close Price	1492.00	2504.64	1961.20	1723.27	1696.57	2075.90
PE Ratio	31.44	15.92	14.60	16.89	16.37	16.39
PS Ratio	0.56	0.98	0.82	0.82	0.85	1.06
PB Ratio	0.62	1.10	0.88	0.88	0.93	1.18
P/FCF Ratio	10.42	11.96	-10.99	-18.76	-36.38	-14.50
P/OCF Ratio	8.69	11.45	-12.67	-28.27	11.55	96.95
EV/Sales Ratio	0.95	1.04	1.03	0.91	1.01	1.17
EV/EBITDA Ratio	19.69	22.33	23.15	13.38	13.64	11.96
EV/EBIT Ratio	44.88	52.06	56.02	18.74	17.12	14.14
EV/FCF Ratio	9.49	12.64	-13.73	-20.85	-43.07	-16.06
Debt / Equity Ratio	0.16	0.15	0.27	0.24	0.25	0.22
Debt / EBITDA Ratio	3.04	2.91	5.68	3.31	3.11	1.97
Debt / FCF Ratio	1.47	1.65	-3.37	-5.16	-9.81	-2.64
Asset Turnover	0.79	0.83	0.81	0.78	0.80	0.87
Inventory Turnover	3.46	3.42	3.34	3.11	3.06	3.27
Quick Ratio	2.55	2.66	1.46	2.17	1.66	1.96
Current Ratio	3.68	3.97	2.42	3.39	2.86	3.12
Return on Equity (ROE)	1.94%	6.42%	5.80%	4.71%	5.00%	6.67%
Return on Assets (ROA)	1.05%	1.04%	0.93%	2.37%	2.95%	4.50%
Return on Capital (ROIC)	1.19%	1.16%	1.03%	2.67%	3.35%	5.09%
Earnings Yield	3.18%	5.82%	6.23%	5.25%	5.23%	5.19%
FCF Yield	9.59%	8.36%	-9.10%	-5.33%	-2.75%	-6.90%
Dividend Yield	2.25%	2.00%	-	-	-	-
Payout Ratio	105.38%	31.79%	24.80%	32.73%	31.20%	20.39%
Buyback Yield / Dilution	-0.15%	0.06%	-0.21%	0.24%	-1.64%	-0.03%
Total Shareholder Return	-0.15%	2.06%	-0.21%	0.24%	-1.64%	-0.03%

Source: S&P Capital IQ. Standard template. Financial Sources.